Celecoxib and Hyperuricaemia - a phase IV clinical study of FDA data

Summary:

Hyperuricaemia is reported as a side effect among people who take Celecoxib (celecoxib), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Febuxostat, and have Urinary tract infection.

The phase IV clinical study analyzes which people have Hyperuricaemia when taking Celecoxib. It is created by eHealthMe based on reports of 37,974 people who have side effects when taking Celecoxib from the FDA, and is updated regularly.

What is Celecoxib?

Celecoxib has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 38,217 Celecoxib users. Check the latest studies of Celecoxib.

What is Hyperuricaemia?

Hyperuricaemia (level of uric acid in the blood that is abnormally high) is found to be associated with 701 drugs and 791 conditions by eHealthMe. Check the latest studies of Hyperuricaemia.

On Jul, 17, 2026

37,974 people reported to have side effects when taking Celecoxib.
Among them, 25 people (0.07%) have Hyperuricaemia.

Among these 25 people:

How long have people been on Celecoxib when they have Hyperuricaemia? *

What is the gender of people who have Hyperuricaemia when taking Celecoxib? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Hyperuricaemia when taking Celecoxib? *

What are other drugs people take besides Celecoxib? *

What are other side effects people have besides Hyperuricaemia? *

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 9 people, 36.00%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 7 people, 28.00%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 6 people, 24.00%
Acidosis (build-up of carbon dioxide in the blood): 6 people, 24.00%
Pain In Extremity: 6 people, 24.00%
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 5 people, 20.00%
Acute Kidney Failure: 5 people, 20.00%
Oedema Peripheral (superficial swelling): 5 people, 20.00%
Dry Eye Syndrome: 4 people, 16.00%
Hair Loss: 4 people, 16.00%

What are the existing conditions these people have? *

Urinary Tract Infection: 7 people, 28.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 16.00%
Pain In Extremity: 4 people, 16.00%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 12.00%
High Blood Pressure: 3 people, 12.00%
White Blood Cell Count Decreased: 2 people, 8.00%
Blood Uric Acid Increased: 2 people, 8.00%
Dyschezia (difficulty in defecating): 2 people, 8.00%
Multiple Myeloma (cancer of the plasma cells): 2 people, 8.00%
Inflammation: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Celecoxib and have Hyperuricaemia?

- Check whether Hyperuricaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Celecoxib:

Celecoxib (38,217 reports)

Hyperuricaemia treatments and more:

Hyperuricaemia (25,670 reports)

Browse all side effects of Celecoxib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperuricaemia:

Hyperuricaemia (701 drugs)

Browse all the conditions that are associated with Hyperuricaemia:

Hyperuricaemia (791 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on celecoxib (the active ingredients of Celecoxib) and Celecoxib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.